NEWS FROM USA
NDA Approvals
|
Approval Date |
Drug |
NDA Sponsor |
Brand Name |
Prescribing information |
|
07 Nov 2018 |
Epinephrine Aerosol |
Armstrong |
Primatene Mist |
|
|
09 Nov 2018 |
Revefenacin Solution |
Theravance |
Yupelri |
ANDA Approvals
|
Approval Date |
Drug Product |
ANDA Sponsor |
Corresponding RLD |
Number Of Other Approved Generics |
|
07 Nov 2018 |
Hikma |
Levophed (Hospira) |
Five |
|
|
07 Nov 2018 |
Breckenridge |
Achromycin V (Heritage) |
Three |
|
|
07 Nov 2018 |
Ascent |
None |
Seventeen |
|
|
08 Nov 2018 |
Hi Tech |
N/A |
Three |
|
|
08 Nov 2018 |
Hainan Poly |
Cytovene (Roche) |
Five |
|
|
08 Nov 2018 |
Zydus |
N/A |
Eleven |
|
|
08 Nov 2018 |
Alvogen Pine |
N/A |
Thirteen |
|
|
09 Nov 2018 |
Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Tablets |
Teva |
Atripla (Gilead) |
One (Aurobindo) |
|
09 Nov 2018 |
Beijing |
Arimidex (ANI Pharma) |
Eleven |
|
|
09 Nov 2018 |
Cipla |
Valcyte (Hoffmann) |
Five |
|
|
09 Nov 2018 |
Emcure |
N/A |
Eight |
|
|
09 Nov 2018 |
Aiping |
Tessalon (Pfizer) |
Nine |
|
|
09 Nov 2018 |
Lupin |
Dacogen (Otsuka) |
Seven |
|
|
09 Nov 2018 |
Lupin |
Pulmicort Respules (Astrazeneca) |
Five |
|
|
13 Nov 2018 |
Amring |
Trisenox |
Two (Fresenius, Zydus) |
|
|
13 Nov 2018 |
Zydus |
Trisenox |
Two (Fresenius, Amring) |
|
|
13 Nov 2018 |
Bayshore |
Lomotil (Gd Searle) |
Five |
Tentative NDA Approvals
|
Approval Date |
Drug |
Company |
|
06 Nov 2018 |
Halobetasol Propionate |
Dow Pharm |
Tentative ANDA Approvals
|
Approval Date |
Drug |
Company |
|
06 Nov 2018 |
Ticagrelor |
Prinston Pharma |
|
09 Nov 2018 |
Mesalamine |
Pharma Sourcing |
|
09 Nov 2018 |
Ticagrelor |
Alkem |
|
09 Nov 2018 |
Solifenacin Succinate |
Glenmark Pharms |
|
09 Nov 2018 |
Dimethyl Fumarate |
Shilpa Medicare |
|
09 Nov 2018 |
Bortezomib |
Qilu Pharma |
NEW GENERICS LAUNCHES IN US
|
DRUG |
COMPANY |
Corresponding RLD |
Annual sales quoted in press release as per IQVIA |
Press Release |
|
Atovaquone Oral Suspension |
Lupin |
Mepron (GSK) |
$119 Million |
USFDA Inspection
Lupin's Nagpur Facility Receives EIR From US FDA
Now, you can also follow us on twitter @pharmacaptions. If you have any query/suggestion then please write us at pharmacaption@gmail.com
No comments:
Post a Comment